Opaleye Management reports $29,593 Grace Therapeutics common share purchase

GRCE•2026-10-13

Opaleye Management, a 10% owner of Grace Therapeutics, reported open-market purchases of 14,632 common shares for a total of $29,593. Indirect beneficial ownership rose to 2,873,289 shares held through Opaleye, L.P.

Opaleye Management reports $29,593 Grace Therapeutics common share purchase

1. Share purchases

Related News

Accenture COO Catherine Kiernan Hogan disposes of shares worth $149,296.56

Televisa to buy 50% stake in AT&T México for $2 billion

BitFuFu September daily bitcoin production steady at 5.6 BTC; self-mining production 98 BTC

Sources

Opaleye Management reports $29,593 Grace Therapeutics common share purchase

Enovix receives 100,000-battery drone order

LogicMark shareholders receive $1.31 per share as merger closes